International Home Dialysis Consortium: Declaration Advocating for the Promotion of Home Dialysis Globally
The use of home dialysis (peritoneal dialysis [PD] and home hemodialysis [HHD]) is variable in high-income countries despite its known lifestyle benefits and lower costs, and is unavailable or underused in many lower-income countries, where PD could increase access to dialysis. The International Home Dialysis Consortium (IHDC) is a joint project of the ISN and the International Society for Peritoneal Dialysis (ISPD). The consortium has been established to address the challenges and barriers to and improve the adoption of home dialysis globally. A launch meeting was held at the World Congress of Nephrology 2024 in Buenos Aires, Argentina, focusing on 4 areas-empowering people needing dialysis, nephrology workforce education, developing workforce and resources, and integrating care and payment policies. The key statements from each group were then amalgamated to produce a manifesto that advocates for the global promotion of home dialysis (PD and HHD) to enhance patient experience, quality, and equity in kidney failure care. This manifesto will be presented to professional kidney-related societies (medical, nursing, patients, and technical) to adopt the declaration as a practical roadmap to increase home dialysis awareness and, consequently, modality selection.
Authors
- Christopher T. Chan (ORCID: https://orcid.org/0000-0002-0947-7273)
- Edwina A. Brown (ORCID: https://orcid.org/0000-0002-4453-6486)
- Rajnish Mehrotra (ORCID: https://orcid.org/0000-0003-2833-067X)
- Anjali Saxena (ORCID: https://orcid.org/0009-0006-2178-7801)
- Sandip Mitra (ORCID: https://orcid.org/0000-0003-0389-636X)
- Brigitte Schiller (ORCID: https://orcid.org/0000-0003-4705-9723)
- Vivekanand Jha (ORCID: https://orcid.org/0000-0002-8015-9470)
- Adrian Liew (ORCID: https://orcid.org/0000-0002-0963-6270)
- Claus Peter Schmitt (ORCID: https://orcid.org/0000-0002-9688-9515)
- Sunita Bavanandan (ORCID: https://orcid.org/0000-0001-5521-6480)
- Peter Rutherford (ORCID: https://orcid.org/0000-0003-2425-4358)
- Irma Tchokhonelidze (ORCID: https://orcid.org/0000-0003-2303-6631)
- Magdalena Madero (ORCID: https://orcid.org/0000-0002-8154-8339)
- Abdou Niang (ORCID: https://orcid.org/0000-0002-4025-0990)
- Sydney C.W. Tang (ORCID: https://orcid.org/0000-0002-6862-1941)
- Simon Davies (ORCID: https://orcid.org/0000-0001-5127-4755)
- Ana Figueirido
Institutions
- Northwest Kidney Centers (US)
- University Health Network (CA)
- Imperial College Healthcare NHS Trust (GB)
- Manipal Academy of Higher Education (IN)
- University of Toronto (CA)
- University of Washington (US)
- Heidelberg University (DE)
- Hospital Kuala Lumpur (MY)
- Manchester Academic Health Science Centre (GB)
- University Hospital Heidelberg (DE)
- Mount Elizabeth Novena Hospital (SG)
- University of Manchester (GB)
- Intuitive Surgical (Switzerland) (CH)
- Fresenius Medical Care (United States) (US)
- George Institute for Global Health (IN)
- Instituto Nacional de Cardiología (MX)
- Fresenius Medical Care North America (United States) (US)
- Pontifícia Universidade Católica do Rio Grande do Sul (BR)
- Imperial College London (GB)
- Keele University (GB)
- Tbilisi State Medical University (GE)
- Heidelberg University (US)
- University of Hong Kong (HK)
- Cheikh Anta Diop University (SN)
- Stanford University (US)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-03-14
- DOI
- https://doi.org/10.1016/j.ekir.2025.03.012
- Citations
- 4
- Primary Topic
- Dialysis and Renal Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 5.72
Funders
- American Society of Nephrology
- AstraZeneca
- Bayer
- GlaxoSmithKline
- Alexion Pharmaceuticals
- Alnylam Pharmaceuticals
- Arrowhead Pharmaceuticals
- BioCryst
- Fresenius Medical Care North America
- Imperial College London
- Deutsche Forschungsgemeinschaft